
Quality Management in Cytopathology
Christopher O'Conor, MD, PhD |
Quality assurance is an essential component of laboratory operations. Cytopathology laboratories face unique challenges related to heavily manual and custom workflows in addition to high rates of ancillary testing and fragmented information technology systems. At the same time, there are unique opportunities to leverage quality data into systems improvement. This webinar will review mandated and nonmandated quality metrics and how they can be utilized in daily practice to monitor and optimize laboratory workflow and performance. This webinar will describe how quality metrics can be designed, implemented, and customized to individual laboratories, and elucidate new tools for automation that can enhance the efficiency, efficacy, and flexibility of system workflows. The webinar will utilize case-based discussions to highlight common sources of error and explore approaches and applications of quality tools.
Target Audience
This educational activity is designed for pathologists, cytopathologists, cytotechnologists, students and other members of the cytopathology community.
Learning Objectives
- Review quality metrics cytopathology laboratories are required to collect and explore alternative (optional) metrics that can be effectively utilized to optimize laboratory operations.
- Describe specific ways to utilize quality metric tracking to identify laboratory inefficiencies.
- Develop an understanding of quality tools that can be utilized in system operations such as root cause analysis.
- Explore common sources of laboratory errors and system vulnerabilities using quality tools to identify areas for system improvements through case-based discussions.
Presenter(s):
Christopher O'Conor, MD, PhD
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
The faculty, committee members, Executive Board and staff who are in position to control the content of this activity are required to disclose to the ASC and to learners any financial relationships that have occurred within the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ASC has reviewed the disclosures and mitigated all relevant financial relationships.
The following individuals have reported financial relationships:
Christopher J. VandenBussche MD PhD: Ad hoc advisory board panel and Consultant – Roche
The following individuals have reported no relevant financial relationships:
Susan Alperstein, MS, CT(ASCP), Kristen Atkins, MD, Catherine Bammert, PhD, CT, MB(ASCP), Christine Booth, MD, Deborah Chute, MD, Amy Clayton, MD, Jacqueline Cuda, BS, SCT(ASCP), Fang Fan, MD, PhD, Beverly Haigler-Daly, BS, CT(ASCP), Michael Henry, MD, Oscar Lin, MD, PhD, Sean McNair, MPH, CT(ASCP), Michelle Reid, MD, Sinchita Roy-Chowdhuri, MD, PhD, Momin Siddiqui, MD, FIAC, Liron Pantanowitz, MD, PhD, MHA, Michelle Reid, MD, Sinchita Roy-Chowdhuri, MD, PhD, Momin Siddiqui, MD, FIAC, Michael Thrall, MD, Vivian Weiss, MD, PhD, Donna Armylagos, BA CT(ASCP), Cheryl K. Arnott, SCT(ASCP), Bonnie Choy, MD, Saroja Devi Geetha, MBBS, Elizabeth Jacobi, MD, Jennifer B. Kernodle-Zimmer, BS, SCT(ASCP), Zaibo Li, MD, PhD, Steven Long, MD, Judy Pang, MD, Ami Patel, MD, Maria Luisa Policarpio-Nicolas, MD, Jose Victor Scarpa Carniello, MD, Sheila Segura, MD, Paul Staats, MD, Peter Wanes, MD
The ASC staff associated with the development of content for this activity reported no relevant financial relationships.
Presenters:
The presenter has no conflicts of interest or financial relationships to disclose.
Continuing Medical Education (CME) Statement
The American Society of Cytopathology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Cytopathology designates this enduring educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
American Board of Pathology Continuing Certification (CC)
This product can help fulfill the CME requirements mandated by the American Board of Pathology Continuing Certification (CC) process. Earn up to 2.0 Credit Hours.
Continuing Medical Laboratory Education (CMLE)
The ASC designates this activity for a maximum of 2.0 Continuing Medical Laboratory Education (CMLE) credit hours for non-physicians. The CMLE credit hours meet the continuing education requirements for the ASCP Board of Registry Certification Maintenance Program. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Cytotechnologists with Licenses in Florida and California
This program is approved for 2 continuing education credits in the State of Florida and 1 in the State of California. The credit on each link is good for three years from the live presentation date.
Available Credit
- 2.00 AMA PRA Category 1 Credit™
- 1.00 California Credits
- 2.00 CMLE
- 2.00 Florida Credits
- 2.00 Participant